Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-18

Clinical Trial Update: Dissecting Host-microbiome Modifiers of Type 2 Diabetes Risk [NA]

View source ↗

Summary

This Laval University clinical trial investigates how host-microbiome factors influence the risk of developing Type 2 diabetes mellitus and is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Laval University | Conditions: Type 2 Diabetes | NA | Status: RECRUITING